参考文献/References:
[1] Barras M A,Kirkpatrick C M J,Green B.Current dosing of low-molecular-weight heparins does not reflect licensed product labels: an international survey [J].British Journal of Clinical Pharmacology,2010,69(5): 520-528.
[2] Pourghaznein T,Azimi A V,Jafarabadi M A.The effect of injection duration and injection site on pain and bruising of subcutaneous injection of heparin[J].Journal of Clinical Nursing,2013,49(3):12-22.
[3] Chan H.Effects of injection duration on site pain intensity and bruising as sociated with subcutaneous heparin [J].J Adv Nurs,2001,35(6):882-892.
[4] 张菊霞,马玉霞,温玉洁,等.皮下注射低分子肝素时不同推注时间对皮下出血的影响[J].中华护理杂志,2014,49(2): 233-235.
[5] McConnell E A.Dos & donts:administering subcutaneous heparin[J].Nursing,2000,30:17-18.
[6] 耿洪业.实用内科药物治疗学[M].北京:人民卫生出版社,2000:340.
[7] 高戈,高春华.磺达肝葵钠和低分子肝素致皮下出血临床观察[J].实用药物与临床,2012,15(1):57-58.
[8] 高亚莉.低分子肝素注射方法的改进对皮下出血的影响[J].中华全科医学,2013,11(9):1491-1492.
[9] 张柱花.酚妥拉明与低分子肝素钙联用治疗肺心病的临床效果观察[J].临床研究,2018,26(1):125-127.
[10] 金歌,屈清荣,王俊平,等.皮下注射低分子肝素优势方案研究[J].护理学杂志,2016,31(9): 55-57.